Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

‘Innovation’ nation

Nature Biotechnology volume 37, pages1264–1276(2019)Cite this article

China is finally embracing biopharmaceutical innovation, but it is innovation that looks different from that in the West.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Fig. 1: Size of pool of Chinese students in the United States annually from 2000 to 2018.
Fig. 2: Private investment in Chinese and European biotech companies.
Fig. 3: Countries where key discoveries for new therapeutic modalities have been made since biotech’s inception.
Fig. 4: Granted Chinese invention biotech patents by country of first filing, 2009–2018.
Fig. 5: Lagging life sciences.

Author information

Affiliations

  1. Business Editor, Nature Biotechnology

    Brady Huggett

Authors
  1. Brady Huggett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brady Huggett.

Supplementary material

Supplementary Table 1

Ties to the West

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huggett, B. ‘Innovation’ nation. Nat Biotechnol 37, 1264–1276 (2019). https://doi.org/10.1038/s41587-019-0306-9

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing